FINHUB Insights

ZBH · Q2 FY25 · Apr 1 – Jun 30, 2025

Zimmer Biomet Q2 FY25: where the revenue came from and where it went

Zimmer Biomet Q2 FY25: revenue $2.1B (+7% year over year). Net profit $0.15B. Largest cohort Knees $0.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2025
Reported
Aug 7, 2025 10-Q
Sankey diagram of Zimmer Biomet's income statement for Q2 FY25: revenue of $2.08 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$2.08B +7% year over year
Gross profit$1.49B 71% margin
Operating profit$0.30B 14% margin
Net profit$0.15B 7% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
ItemValueShare of revenueYear over year
Revenue 2.08 100% +7%
Knees 0.83 40% +3%
SET 0.55 27% +17%
Hips 0.54 26% +6%
Technology & data bone 0.17 8% +0%
Cost of revenue−0.5929%
Gross profit1.4971% margin+0pp
SG&A−0.8239%+1pp
Other−0.3718%+0pp
Operating profit0.3014% margin−4pp
Tax−0.07
Interest & other costs−0.08
Net profit0.157%−5pp
Filing on EDGAR More quarters of ZBH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.